DOCS.L vs GCO
DOCS.L: Dr. Martens is a globally recognized footwear brand rooted in cultural heritage, known for its durable, iconic boots and air-cushioned soles. GCO: Genesco is a footwear-focused specialty retailer operating iconic brands including Journeys, Schuh, and Johnston & Murphy, currently executing a strategy to improve profitability through footprint optimization and a shift to full-price selling.
Side-by-side fundamentals
| Metric | DOCS.L | GCO | Edge |
|---|---|---|---|
| Price | £0.679 | $36.87 | |
| Market cap | $848M | $399M | |
| P/E | 27.16 | 25.03 | GCO lower |
| Net margin | +3.1% | +0.5% | DOCS.L higher |
| Gross margin | +66.2% | +46.3% | DOCS.L higher |
| Operating margin FY2026, SEC XBRL | n/a | +0.7% | |
| ROE | +6.6% | +2.3% | DOCS.L higher |
| ROA FY2026, SEC XBRL | n/a | +1.0% | |
| Debt / equity as of 2026-09-03 | n/a | 0.08 | |
| Revenue growth (YoY) as of 2026-09-03 | n/a | +4.6% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +0.7% | |
| Dividend streak (yrs) SEC XBRL | n/a | 0 | |
| Beta as of 2026-09-03 | n/a | 1.76 | |
| 1-year return | -24.7% | +29.0% | GCO higher |
Fundamentals: SEC XBRL company filings and annual report filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.